About

Mechanical circulatory support has emerged as an important therapy for advanced heart failure. These devices significantly improve survival and quality of life and should be considered in every patient with end-stage heart failure with reduced ejection fraction who has no other life-limiting diseases.

Devices, such as implantable cardioverter-defibrillators (ICDs), and novel pacing technologies, including cardiac resynchronisation therapy (CRT), have helped to complement goal-directed medical therapy and positively impact prognosis in these patients, as demonstrated in multiple high-quality clinical trials.

Articles

Clinical Experience of a Real-world Heart Recovery Programme

Published:

28 June 2022

Citation:

Interventional Cardiology Review 2022;17(Suppl 1):31–2.

Fundamentals of Heart Recovery Versus Remission

Published:

28 June 2022

Citation:

Interventional Cardiology Review 2022;17(Suppl 1):29–30.

Distinguished Lecture: Heart Recovery – Insights from RESTAGE-HF

Published:

28 June 2022

Citation:

Interventional Cardiology Review 2022;17(Suppl 1):27–8.

Impella-supported MitraClip in Cardiogenic Shock Patients Complicated With High-grade Mitral Regurgitation

Published:

28 June 2022

Citation:

Interventional Cardiology Review 2022;17(Suppl 1):26.